Determinants of serious health outcome-free status in middle-aged and older people with dysglycaemia: Exploratory analysis of the ORIGIN trial.
Kamel MohammediSibylle HessMatthew McQueenMarie PigeyreShun Fu LeeGuillaume PareUlagamadesan VenkatesanPublished in: Diabetes, obesity & metabolism (2024)
A set of routinely measured clinical characteristics and seven protein biomarkers identify middle-aged and older people with prediabetes or early type 2 diabetes as least likely to experience serious outcomes during follow-up.
Keyphrases
- type diabetes
- glycemic control
- public health
- healthcare
- study protocol
- phase iii
- clinical trial
- mental health
- physical activity
- phase ii
- community dwelling
- middle aged
- cardiovascular disease
- health information
- protein protein
- insulin resistance
- binding protein
- health promotion
- randomized controlled trial
- adipose tissue
- human health
- risk assessment
- climate change
- weight loss
- double blind